B-Cell Chronic Lymphocytic Leukemia Treatment Market Report

Global and Region B-Cell Chronic Lymphocytic Leukemia Treatment Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：199
  • REPORT CODE：GMM947937
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of B-Cell Chronic Lymphocytic Leukemia Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of B-Cell Chronic Lymphocytic Leukemia Treatmentmarket, defines the market attractiveness level of B-Cell Chronic Lymphocytic Leukemia Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of B-Cell Chronic Lymphocytic Leukemia Treatment industry, describes the types of B-Cell Chronic Lymphocytic Leukemia Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global B-Cell Chronic Lymphocytic Leukemia Treatment market and the development prospects and opportunities of B-Cell Chronic Lymphocytic Leukemia Treatment industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global B-Cell Chronic Lymphocytic Leukemia Treatment market in Chapter 13.

    By Player:

    • AB Science SA

    • Immunomedics, Inc

    • Elsalys Biotech SAS

    • iDD biotech SAS

    • Molecular Templates Inc

    • Johnson & Johnson

    • Amgen Inc

    • Dynavax Technologies Corporation

    • Noxxon Pharma AG

    • F Hoffmann-La Roche Ltd

    • Celgene Corporation

    • Eisai

    • Juno Therapeutics Inc

    By Type:

    • AMG-319

    • ATTCK-20

    • IDD-002

    • JNJ-64052781

    • Lenalidomide

    • MAT-303

    • MT-3724

    • Others

    By End-User:

    • Clinic

    • Hospital

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 B-Cell Chronic Lymphocytic Leukemia Treatment Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 B-Cell Chronic Lymphocytic Leukemia Treatment Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 B-Cell Chronic Lymphocytic Leukemia Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 B-Cell Chronic Lymphocytic Leukemia Treatment Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis and Outlook to 2022

    • 7.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption (2017-2022)

    • 7.2 United States B-Cell Chronic Lymphocytic Leukemia Treatment Consumption (2017-2022)

    • 7.3 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Consumption (2017-2022)

    • 7.4 China B-Cell Chronic Lymphocytic Leukemia Treatment Consumption (2017-2022)

    • 7.5 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Consumption (2017-2022)

    • 7.6 India B-Cell Chronic Lymphocytic Leukemia Treatment Consumption (2017-2022)

    • 7.7 South Korea B-Cell Chronic Lymphocytic Leukemia Treatment Consumption (2017-2022)

    8 Region and Country-wise B-Cell Chronic Lymphocytic Leukemia Treatment Market Analysis and Outlook to 2028

    • 8.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast (2022-2028)

    • 8.2 United States B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast (2022-2028)

    • 8.3 Europe B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast (2022-2028)

    • 8.4 China B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast (2022-2028)

    • 8.5 Japan B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast (2022-2028)

    • 8.6 India B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast (2022-2028)

    • 8.7 South Korea B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast (2022-2028)

    9 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global AMG-319 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global ATTCK-20 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global IDD-002 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global JNJ-64052781 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Lenalidomide Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global MAT-303 Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global MT-3724 Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Outlook by Types and Applications to 2028

    • 10.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global AMG-319 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global ATTCK-20 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global IDD-002 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global JNJ-64052781 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Lenalidomide Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global MAT-303 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global MT-3724 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.8 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global B-Cell Chronic Lymphocytic Leukemia Treatment Import and Export Analysis (Top 5 Countries)

    • 11.1 Global B-Cell Chronic Lymphocytic Leukemia Treatment Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global B-Cell Chronic Lymphocytic Leukemia Treatment Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 B-Cell Chronic Lymphocytic Leukemia Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Competitive Analysis

    • 14.1 AB Science SA

      • 14.1.1 AB Science SA Company Details

      • 14.1.2 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • 14.2 Immunomedics, Inc

      • 14.2.1 Immunomedics, Inc Company Details

      • 14.2.2 Immunomedics, Inc B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Immunomedics, Inc B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • 14.3 Elsalys Biotech SAS

      • 14.3.1 Elsalys Biotech SAS Company Details

      • 14.3.2 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • 14.4 iDD biotech SAS

      • 14.4.1 iDD biotech SAS Company Details

      • 14.4.2 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • 14.5 Molecular Templates Inc

      • 14.5.1 Molecular Templates Inc Company Details

      • 14.5.2 Molecular Templates Inc B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Molecular Templates Inc B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • 14.6 Johnson & Johnson

      • 14.6.1 Johnson & Johnson Company Details

      • 14.6.2 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • 14.7 Amgen Inc

      • 14.7.1 Amgen Inc Company Details

      • 14.7.2 Amgen Inc B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Amgen Inc B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • 14.8 Dynavax Technologies Corporation

      • 14.8.1 Dynavax Technologies Corporation Company Details

      • 14.8.2 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • 14.9 Noxxon Pharma AG

      • 14.9.1 Noxxon Pharma AG Company Details

      • 14.9.2 Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • 14.10 F Hoffmann-La Roche Ltd

      • 14.10.1 F Hoffmann-La Roche Ltd Company Details

      • 14.10.2 F Hoffmann-La Roche Ltd B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 F Hoffmann-La Roche Ltd B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • 14.11 Celgene Corporation

      • 14.11.1 Celgene Corporation Company Details

      • 14.11.2 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • 14.12 Eisai

      • 14.12.1 Eisai Company Details

      • 14.12.2 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • 14.13 Juno Therapeutics Inc

      • 14.13.1 Juno Therapeutics Inc Company Details

      • 14.13.2 Juno Therapeutics Inc B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Juno Therapeutics Inc B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of B-Cell Chronic Lymphocytic Leukemia Treatment

    • Figure B-Cell Chronic Lymphocytic Leukemia Treatment Picture

    • Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption by Country (2017-2022)

    • Figure United States B-Cell Chronic Lymphocytic Leukemia Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe B-Cell Chronic Lymphocytic Leukemia Treatment Consumption and Growth Rate (2017-2022)

    • Figure China B-Cell Chronic Lymphocytic Leukemia Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan B-Cell Chronic Lymphocytic Leukemia Treatment Consumption and Growth Rate (2017-2022)

    • Figure India B-Cell Chronic Lymphocytic Leukemia Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea B-Cell Chronic Lymphocytic Leukemia Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure China B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea B-Cell Chronic Lymphocytic Leukemia Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AMG-319 Consumption and Growth Rate (2017-2022)

    • Figure Global ATTCK-20 Consumption and Growth Rate (2017-2022)

    • Figure Global IDD-002 Consumption and Growth Rate (2017-2022)

    • Figure Global JNJ-64052781 Consumption and Growth Rate (2017-2022)

    • Figure Global Lenalidomide Consumption and Growth Rate (2017-2022)

    • Figure Global MAT-303 Consumption and Growth Rate (2017-2022)

    • Figure Global MT-3724 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global AMG-319 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ATTCK-20 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IDD-002 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global JNJ-64052781 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lenalidomide Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MAT-303 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MT-3724 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Import by Region (Top 5 Countries) (2017-2028)

    • Table Global B-Cell Chronic Lymphocytic Leukemia Treatment Export by Region (Top 5 Countries) (2017-2028)

    • Table AB Science SA (Foundation Year, Company Profile and etc.)

    • Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AB Science SA B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • Table Immunomedics, Inc (Foundation Year, Company Profile and etc.)

    • Table Immunomedics, Inc B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immunomedics, Inc B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • Table Elsalys Biotech SAS (Foundation Year, Company Profile and etc.)

    • Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Elsalys Biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • Table iDD biotech SAS (Foundation Year, Company Profile and etc.)

    • Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table iDD biotech SAS B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • Table Molecular Templates Inc (Foundation Year, Company Profile and etc.)

    • Table Molecular Templates Inc B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Molecular Templates Inc B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • Table Amgen Inc (Foundation Year, Company Profile and etc.)

    • Table Amgen Inc B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Inc B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • Table Dynavax Technologies Corporation (Foundation Year, Company Profile and etc.)

    • Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dynavax Technologies Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • Table Noxxon Pharma AG (Foundation Year, Company Profile and etc.)

    • Table Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Noxxon Pharma AG B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • Table Celgene Corporation (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • Table Eisai (Foundation Year, Company Profile and etc.)

    • Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eisai B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service

    • Table Juno Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Juno Therapeutics Inc B-Cell Chronic Lymphocytic Leukemia Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Juno Therapeutics Inc B-Cell Chronic Lymphocytic Leukemia Treatment Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US